Researchers have developed shotgun genetic engineering, a method that screens millions of randomly assembled metabolic ...

Researchers have identified and engineered a set of exceptionally strong constitutive promoters from Lactococcus cremoris, ...

Genetic engineering is the act of modifying the genetic makeup of an organism. Modifications can be generated by methods such as gene targeting, nuclear transplantation, transfection of synthetic ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...

Genetic engineering, also known as genetic modification, is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to ...

The modification of the genetic makeup of cells. Genetic engineering modifies the DNA in cells to alter their behavior. In 1953, the discovery of the DNA double helix, technically deoxyribonucleic ...

Influential inventions often combine existing tools in new ways. The iPhone, for instance, amalgamated the telephone, web browser and camera, among many other devices. The same is now possible in gene ...

GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering. This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative ...

A team of scientists created a new gene-editing tool that they claim is more accurate than the industry standard, CRISPR. Researchers from the University of Sydney, Australia, developed what is called ...

APPB-515 is being developed as a locally administered gene therapy designed to provide sustained expression of therapeutic proteins within the joint. The program combines computational protein ...

Colossal Biosciences is working to introduce woolly mammoth traits into Asian elephants through genetic modifications.

Prioritize viral vectors, oncology and rare disease therapies, with North America offering strong ROI potential through regulatory support, R&D investment and early adoptionDublin, Oct. 08, 2026 ...